New Delhi, 31 Dec 2024: With the revised Schedule M guidelines for good manufacturing practices (GMP) to come into force from January 2025, and there’s no likely extension of the deadline for meeting the new norms, the pharma sector is staring at a crisis situation. Experts......
View Details

Related News

• Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)

---

• FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)

---

• Dabur sues Patanjali over toothpaste trade dress (16-01-2025)

---

• Wrappers of drug brands found from Paonta printing press premises (16-01-2025)

---

• PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)

---

• Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)

---

• Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)

---

• SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)

---

• 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)

---

• Three arrested with 900 cough syrup Bottles worth Rs 2 lakh (15-01-2025)

---